Chalcone and curcumin hybrids of indole propargylamines as multifunctional neuroprotective agents
Loading...
Date
2020
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
University of the Western Cape
Abstract
Neurodegenerative disorders (NDs) are a range of chronic brain disorders that includes
amongst others motor function loss. Parkinson’s disease (PD) is one of the common NDs that
has an insidious onset and diagnosed when dopaminergic neurons in the substantia nigra are
already lost. The loss creates a deficiency of the dopamine (neurotransmitter) thereby causing
neurochemical imbalance resulting in the signs and symptoms of PD. NDs overlap at multiple
levels so some of the symptoms overlap as well. NDs currently have no cure yet and current
drug therapies only improve the quality of life of the patients by targeting the symptoms
mainly. Treatment of PD currently involves different classes of drugs and depending on the
stages of the disease, some drugs can be only used as an adjunct therapy. Anti-oxidants and
monoamine oxidase inhibitors (MAO-I) are part of the treatment options.
Description
Magister Pharmaceuticae - MPharm
Keywords
Neurodegenerative disorders, Parkinson’s diseases, Monoamine oxidase, Oxidative stress, Neuroprotection